SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-19-001563
Filing Date
2019-08-09
Accepted
2019-08-09 16:32:52
Documents
53
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inmb_10q.htm 10-Q 386054
2 CERTIFICATION inmb_ex311.htm EX-31.1 8446
3 CERTIFICATION inmb_ex312.htm EX-31.2 8560
4 CERTIFICATION inmb_ex321.htm EX-32.1 3449
5 CERTIFICATION inmb_ex322.htm EX-32.2 3436
12 inmb_10qimg1.jpg GRAPHIC 83692
13 inmb_10qimg2.jpg GRAPHIC 110593
14 inmb_10qimg3.jpg GRAPHIC 96800
  Complete submission text file 0001640334-19-001563.txt   3174470

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT inmb-20190630.xml EX-101.INS 417138
7 XBRL TAXONOMY EXTENSION SCHEMA inmb-20190630.xsd EX-101.SCH 38469
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inmb-20190630_cal.xml EX-101.CAL 27917
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inmb-20190630_def.xml EX-101.DEF 130082
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE inmb-20190630_lab.xml EX-101.LAB 320704
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inmb-20190630_pre.xml EX-101.PRE 232929
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 191013392
SIC: 2836 Biological Products, (No Diagnostic Substances)